Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Syed Arzoo Mehdi"'
Autor:
Ibrahim Azar, Adam Austin, Biplab K. Saha, Seongho Kim, Hyejeong Jang, Ali Al Sbihi, Samer Alkassis, Omid Yazpandanah, Jie Chi, Vikram Dhillon, Hiren J. Mehta, Amit Chopra, Kristoffer Neu, Syed Arzoo Mehdi, Hirva Mamdani
Publikováno v:
Clinical Lung Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::209260d2859601f956acec7aa440410b
https://doi.org/10.1016/j.cllc.2023.04.002
https://doi.org/10.1016/j.cllc.2023.04.002
Publikováno v:
Journal of Clinical Oncology. 40:e21032-e21032
e21032 Background: Use of immune checkpoint inhibitors against advanced stage NSCLC is associated with significant reduction in overall morbidity and mortality. However, despite the survival benefit, tumors invariably relapse. We aim to study pattern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b61347a3972c13cf11e93e196ab22409
https://doi.org/10.1200/jco.2022.40.16_suppl.e21032
https://doi.org/10.1200/jco.2022.40.16_suppl.e21032
Autor:
Azra Raza, Syed Ahmad Jamal Bohkari, Beatrice C. Lampkin, Mary Ann Miller, Syed Arzoo Mehdi, Margaret Masterson, Saba Chughtai, A. Umerani, Shamim Akhtar, N. Yousuf, Y Sheikh
Publikováno v:
Leukemia research. 16(3)
Examination of the proliferative characteristics of myeloblasts was undertaken in situ in bone marrow (BM) biopsies of patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) following sequential infusions of iodo- (IUdR) and b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::816aedf6fdd33d6c21828f962fa9795b
https://pubmed.ncbi.nlm.nih.gov/1560677
https://pubmed.ncbi.nlm.nih.gov/1560677
Publikováno v:
Clinical Oncology Week; 8/22/2023, p729-729, 1p